rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Michael B. Hoffman

Chairman and CEO

Company insider

Files Form 4 as: Chairman and CEO, Translational Development Acquisition; Director and 10% owner, Annovis Bio; Director and 10% owner, Traws Pharma; Director, Buckeye Partners L P.

Every Form 4 they filed

In numbers

Trades disclosed
107
Buys
18
Sells
5
Bought
$23.4M
Sold
$579K
Companies
4
Companies where not an officer
3
First trade
20 Sep 2006
Last trade
27 May 2026
Last filed
29 May 2026

Companies traded

Where they are an officer
TDAC Translational Development AcquisitionDirector, Officer · Funds, Shells & SPACs · last 27 May 20260 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
ANVS Annovis BioDirector, 10% owner · Biotechnology · last 20 May 20269 buys · 0 sells
TRAW Traws PharmaDirector, 10% owner · Biotechnology · last 27 Aug 20209 buys · 4 sells
Buckeye Partners L PDirector · last 20 Sep 20060 buys · 1 sell

Activity over time

1 Nov 2024 – 1 Oct 2026
04Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
27 May 2026filed 29 May 2026TDAC Translational Development Acquisitionoption or derivative · Funds, Shells & SPACsSEC FORM 4 Code P$42K53,395 at $0.7918filing
27 May 2026filed 29 May 2026TDAC Translational Development Acquisitionoption or derivative · Funds, Shells & SPACsSEC FORM 4 Code P$42K53,395 at $0.79filing
20 May 2026filed 21 May 2026ANVS Annovis BioBiotechnologySEC FORM 4 Bought$4,4842,562 at $1.75filing
20 May 2026filed 21 May 2026ANVS Annovis BioBiotechnologySEC FORM 4 Bought$34K18,849 at $1.80filing
20 May 2026filed 21 May 2026ANVS Annovis BioBiotechnologySEC FORM 4 Bought$104K54,933 at $1.90filing
20 May 2026filed 21 May 2026ANVS Annovis BioBiotechnologySEC FORM 4 Bought$4,4842,562 at $1.75filing
20 May 2026filed 21 May 2026ANVS Annovis BioBiotechnologySEC FORM 4 Bought$34K18,849 at $1.80filing
20 May 2026filed 21 May 2026ANVS Annovis BioBiotechnologySEC FORM 4 Bought$104K54,933 at $1.90filing
2 Apr 2026filed 3 Apr 2026ANVS Annovis BioBiotechnologySEC FORM 4 Bought$1.5M713,800 at $2.10filing
2 Apr 2026filed 3 Apr 2026ANVS Annovis BioBiotechnologySEC FORM 4 Bought$1.5M713,800 at $2.10filing
8 Dec 2025filed 8 Dec 2025ANVS Annovis BioBiotechnologySEC FORM 4 Bought$130K30,000 at $4.34filing
8 Dec 2025filed 8 Dec 2025ANVS Annovis BioBiotechnologySEC FORM 4 Bought$64K15,000 at $4.24filing
24 Nov 2025filed 25 Nov 2025ANVS Annovis BioBiotechnologySEC FORM 4 Bought$6,1501,489 at $4.13filing
24 Nov 2025filed 25 Nov 2025ANVS Annovis BioBiotechnologySEC FORM 4 Bought$35K9,200 at $3.85filing
24 Nov 2025filed 25 Nov 2025ANVS Annovis BioBiotechnologySEC FORM 4 Bought$1,718415 at $4.14filing
24 Nov 2025filed 25 Nov 2025ANVS Annovis BioBiotechnologySEC FORM 4 Bought$117K28,096 at $4.15filing
24 Nov 2025filed 25 Nov 2025ANVS Annovis BioBiotechnologySEC FORM 4 Bought$6,1501,489 at $4.13filing
24 Nov 2025filed 25 Nov 2025ANVS Annovis BioBiotechnologySEC FORM 4 Bought$35K9,200 at $3.85filing
24 Nov 2025filed 25 Nov 2025ANVS Annovis BioBiotechnologySEC FORM 4 Bought$1,718415 at $4.14filing
24 Nov 2025filed 25 Nov 2025ANVS Annovis BioBiotechnologySEC FORM 4 Bought$117K28,096 at $4.15filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care22
Not placed1

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.